Internal Medicine, Endocrinology, Diabetes, & Metabolism · Lancaster, OH
NPI
1700865722
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
2405 N Columbus St, Suite 130
Lancaster, OH, 43130
Phone (740) 689-6710
Groups this clinician bills Medicare through
Medicare paid, 2024
$71K
1,213 services
Medicare patients, 2024
363
Average age 72
Drug cost, 2024
$4.1M
8,448 prescriptions
Company payments, 2025
$1,131
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Assem Houssein was code 99214 (office e&m - established), 664 times for 322 patients. In total Assem Houssein billed 1,213 services in 35 codes, and Medicare paid $71K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-08-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 664 | 322 | $84.79 | $56K |
| 95251 Test - Miscellaneous | Office | 206 | 113 | $24.78 | $5,105 |
| 99213 Office E&M - Established | Office | 55 | 46 | $43.38 | $2,386 |
| 36415 Venipuncture Blood Collection | Office | 47 | 34 | $8.65 | $407 |
| 83036 Blood Count | Office | 37 | 27 | $9.52 | $352 |
| 84443 Clinical Chemistry | Office | 23 | 20 | $16.46 | $379 |
| 80048 Clinical Chemistry | Office | 22 | 19 | $8.29 | $182 |
| 84439 Clinical Chemistry | Office | 22 | 19 | $8.84 | $194 |
| 82570 Clinical Chemistry | Office | 17 | 16 | $5.08 | $86.36 |
| 80061 Clinical Chemistry | Office | 17 | 16 | $13.12 | $223 |
| 82043 Clinical Chemistry | Office | 17 | 16 | $5.66 | $96.22 |
| 80053 Clinical Chemistry | Office | 14 | 14 | $10.35 | $145 |
| 99205 Office E&M - New | Office | 13 | 13 | $163.82 | $2,130 |
By year: 2022 $115K for 2,310 services; 2023 $103K for 1,863 services; 2024 $71K for 1,213 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 47 | 34 | $8.65 | $407 |
| 83036 Blood Count | 37 | 27 | $9.52 | $352 |
| 84443 Clinical Chemistry | 23 | 20 | $16.46 | $379 |
| 84439 Clinical Chemistry | 22 | 19 | $8.84 | $194 |
| 80048 Clinical Chemistry | 22 | 19 | $8.29 | $182 |
| 80061 Clinical Chemistry | 17 | 16 | $13.12 | $223 |
| 82043 Clinical Chemistry | 17 | 16 | $5.66 | $96.22 |
| 82570 Clinical Chemistry | 17 | 16 | $5.08 | $86.36 |
| 80053 Clinical Chemistry | 14 | 14 | $10.35 | $145 |
Medicare prescription drug claims, 2024
In 2024, the drug Assem Houssein prescribed most often to Medicare patients was Levothyroxine Sodium, with 985 prescriptions and refills. In total Assem Houssein wrote 8,448 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 985 | 2,361 | 245 | $8,115 |
| Metformin Hcl Generic | 480 | 1,247 | 140 | $3,317 |
| Ozempic Semaglutide | 354 | 607 | 90 | $574K |
| Novolog Flexpen Insulin Aspart | 336 | 599 | 109 | $105K |
| Tresiba Flextouch U-100 Insulin Degludec | 335 | 719 | 107 | $302K |
| Jardiance Empagliflozin | 322 | 680 | 88 | $390K |
| Glimepiride Generic | 301 | 723 | 94 | $2,493 |
| Tresiba Flextouch U-200 Insulin Degludec | 286 | 638 | 75 | $494K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 232 | 535 | 70 | $66K |
| Gabapentin Generic | 228 | 512 | 65 | $3,541 |
| Synthroid Levothyroxine Sodium | 217 | 514 | 57 | $19K |
| Metformin Hcl Er Metformin Hcl | 214 | 597 | 77 | $2,740 |
| Farxiga Dapagliflozin Propanediol | 204 | 384 | 46 | $212K |
| Mounjaro Tirzepatide | 179 | 241 | 34 | $254K |
| Atorvastatin Calcium Generic | 163 | 438 | 60 | $2,673 |
Brand drugs: 4,458 claims; generic drugs: 3,318 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Assem Houssein $1,131 ($1,131 in general payments such as food, travel and fees) from 8 companies. The largest payer was Xeris Pharmaceuticals, Inc. with $286.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.